SEC Form 4 · accession 0001333277-18-000040
CymaBay Therapeutics, Inc. · CBAY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sujal Shah
Officer — Chief Executive Officer · Director
Period of report
Oct 15, 2018
Accepted (ET)
Oct 16, 2018 · 6:21 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001042074
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 15, 2018 | P | 5,000 | $9.90 | A | 100,000 | D |
Table II — derivative securities
No Table II lines on this filing.